Related Experiment Video
Updated: May 29, 2026
13:47
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
What's new in child and adolescent immunizations?
Victoria Niederhauser1, Dian Baker
1University of Tennessee College of Nursing, Knoxville, USA.
The Nurse Practitioner
|September 22, 2011
Summary
Nurse practitioners are key to preventing vaccine-preventable diseases. They achieve this by staying updated on immunization schedules, reducing access barriers, and advocating for families.
Area of Science:
- Public Health
- Pediatrics
- Nursing
Background:
- Vaccine-preventable diseases remain a significant public health concern.
- Effective immunization strategies are crucial for disease prevention in children and adolescents.
- The role of advanced practice nurses in public health initiatives is increasingly recognized.
Purpose of the Study:
- To highlight the essential contributions of nurse practitioners in the prevention of vaccine-preventable diseases.
- To emphasize the importance of continuous education and advocacy by nurse practitioners in immunization programs.
Main Methods:
- This is a conceptual overview, not an empirical study.
- Literature review on the role of nurse practitioners in immunization.
- Analysis of current immunization schedules and barriers to access.
Main Results:
- Nurse practitioners are pivotal in disease prevention through immunization.
- Staying current with immunization schedules and recommendations is vital.
- Addressing barriers and advocating for patients enhances vaccination rates.
Conclusions:
- Nurse practitioners are essential in minimizing vaccine-preventable diseases.
- Proactive engagement in immunization schedules, barrier reduction, and advocacy empowers families and improves public health outcomes.
Related Concept Videos
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...